Elutia INC 8-K filings

NASDAQ

12 Jan 2024

ELUT

8-K: Elutia Inc. Amends Royalty Agreement with Ligand Pharmaceuticals, Increasing Minimum Payments and Waiving Milestone

Elutia Inc. has amended its royalty agreement with Ligand Pharmaceuticals, increasing minimum annual and quarterly payments while waiving a $5 million milestone payment.